Effect of Switching Therapy to Pegaptanib in Eyes With the Persistent Cases of Exudative Age-Related Macular Degeneration

Purpose of this study was to evaluate the efficacy of switching to pegaptanib monotherapy for persistent cases of exudative age-related macular degeneration (AMD). Out of 296 eyes of 296 patients treated with ranibizumab or ranibizumab combined with photodynamic therapy (PDT), 50 eyes of 50 AMD pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiragami, Chieko, Ono, Aoi, Kobayashi, Mamoru, Manabe, Saki, Yamashita, Ayana, Shiraga, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
5800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616293/
https://www.ncbi.nlm.nih.gov/pubmed/25319441
http://dx.doi.org/10.1097/MD.0000000000000116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616293/
https://www.ncbi.nlm.nih.gov/pubmed/25319441
http://dx.doi.org/10.1097/MD.0000000000000116

Ejemplares similares